Management Update

24/02/2026 10:30 NZDT, GENERAL

NZX/ASX Announcement

24 February 2026

Management Update

TruScreen Group Limited (NZX/ASX: TRU), (“TruScreen” or “the Company”), a global leader in AI-enabled cervical cancer screening, wishes to advise that Mr. Martin Dillon, Chief Executive Officer, has been granted a three-month leave of absence and is expected to return to full duties on or around early June.

Martin will be taking leave to support his wife, who is currently receiving palliative care for metastatic breast cancer. The Board extends its full support to Martin and his family during this difficult time and is grateful for his continued commitment to the Company.

During Martin’s absence, Tony Ho, Non-Executive Independent Chairman, will assume executive responsibilities as Executive Chairman on an interim basis. The Board is confident that the current executive team and interim arrangements will ensure continuity of operations.

The Board will provide further updates to the market as appropriate.

Approved for release by the Board.

Ends

For more information, visit www.truscreen.com or contact:

Tony Ho

Executive Chairman

tonyho@truscreen.com

Guy Robertson

Chief Financial Officer

guyrobertson@truscreen.com